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Abstract
Background The aim of the study was to evaluate whether
the use of preventive osteosynthesis after curettage in
benign and primitive low-grade malignant bone tumor
localized in the distal femur in adult patients provides
sufficient mechanical stability to the system as to allow
weight-bearing and reduce the risk of postoperative frac-
ture. Additionally, lower limb function after curettage and
preventive osteosynthesis was evaluated.
Materials and methods We analyzed twelve cases of
benign and low-grade malignant bone lesions of the distal
femur in adult patients treated in our orthopedic department
between 2008 and 2011 with curettage, bone filling and
preventive osteosynthesis. All patients were treated with
curettage with the use of high-speed cutters, plus liquid
nitrogen as local adjuvant in low-grade malignant lesions,
and filling of the lesion with bone graft or allograft or
acrylic cement, followed by osteosynthesis.
Results No fractures or major complications were
observed; good function of the knee was observed.
Conclusion We recommend preventive osteosynthesis
after curettage in patients with very large lesions ([5 cm,
[60 cm3) or high functional requirements, in obese
patients, and when local adjuvants are used.
Level of evidence Level IV retrospective case-series study.
Keywords Bone tumor  Curettage  Pathological
fractures  Osteosynthesis in bone tumor  Bone grafts
Introduction
Curettage is widely used in musculoskeletal oncology to
treat benign, or even aggressive lesions, some cartilaginous
malignant lesions, and bone metastases [1].
The bone cavity resulting after curettage of the neo-
plastic lesion often requires the use of filling systems to
ensure mechanical stability of the system, such as acrylic
cement or bone grafts [2–4].
For most of the benign tumors, intralesional curettage
and subsequent bone filling represents the treatment of
choice, maintaining structural integrity and functional sta-
bility of the bone and adjacent joint. Depending on the
tumor-specific risk of recurrence, adjuvant measures such
as phenol instillation or cryotherapy with liquid nitrogen
may additionally be applied due to their chemical and
physical effects improving the local effect of curettage
[1, 5–7].
However, these surgical techniques do not appear to be
sufficient to ensure adequate mechanical stability in all
cases, with consequent risk of fracture in some patients
(Fig. 1).
The aim of the study was therefore to evaluate whether
the use of preventive osteosynthesis after curettage in
benign and primitive malignant bone tumors localized in
the distal femur of adult patients provides sufficient
mechanical stability to the system such as to allow load-
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bearing and reduce the risk of postoperative fracture.
Additionally, lower limb function after curettage and pre-
ventive osteosynthesis was evaluated.
Materials and methods
Between 2008 and 2011, twelve cases of benign and low-
grade malignant bone lesions of the distal femur in adult
patients were treated in our department with curettage,
filling with bone or cement and preventive osteosynthesis.
Patients were enrolled retrospectively and a final follow-
up was performed.
The mean age of patients (8 females and 4 males) was
31.6 ± 9.6 years (range 18–47 years).
All cases presented with unilateral lesions in the distal
femur. The bone lesions of the patients with giant cell tumors
and low-grade chondrosarcomawere filledwith bone cement
to take advantage of its adjuvant effect, while the remaining
benign bone lesions were filled with allograft or bone graft.
Adjuvant treatments were considered only in low-grade
chondrosarcoma, giant cell tumors, chondroma and chon-
dromixoid fibroma with liquid nitrogen (because absolute
certainty of benignity of the lesion can only be assessed
based on the entire specimen) to reduce the risk of local
recurrence, improving the results of curettage alone [1, 4].
Demographics, clinical characteristics, histology and
treatment of patients in our case series are described in
Table 1.
The plates used were the Less Invasive Stabilization
System (LISS, Synthes) or the Locking Compression
Plate 4.5 (Synthes).
Before treatment, all patients underwent comprehensive
clinical and imaging assessment, including plain radio-
graphs, computerized tomography (CT) and/or magnetic
resonance imaging (MRI).
All patients were treated after surgery with a prophy-
lactic dose of low molecular weight heparin, depending on
weight and presence of risk factors for thrombofilia, for 5
weeks, and wore antithrombotic stockings. The following
parameters were evaluated at follow-up: range of motion
(ROM), complications, surgical revision, knee society
scoring system (KSS).The clinical assessment of the
patients through ROM and the KSS score was performed
before and after the first surgery and after hardware
removal (AHR). The hardware was removed in all patients
after at least 1 year after surgery. The hardware was also
removed in patients that had cement filling to reduce plate
impingement, to try to obtain a better ROM, and because
the patients were young (range 18–47 years).
Written informed consent was obtained from the
patients for publication of this case series and any
accompanying images. A copy of the written consent is
available for review by the Editor of this journal.
Ethical approval was obtained from the Ethical Com-
mittee of the Catholic University of Sacred Heart in Rome.
Results
The surgical treatment consisted of curettage with the use
of high-speed cutters, local adjuvant in selected cases and
filling of the lesion with bone graft (2 cases), allograft (6
cases) and acrylic cement (4 cases), followed by fixation by
plates with locked screws (Fig. 2).
All operations were performed by the same orthopedic
surgeon.
No patient received chemotherapy or radiotherapy.
The minimum duration of follow-up was 36 months
(range 36–72 months).
In the postoperative period, patients underwent early
mobilization and continuous active and passive leg
Fig. 1 A low-grade chondrosarcoma of the femur (a) treated with curettage, filling and Kirschner wires (b). A fracture followed this procedure
(c), treated through fixation with plate and locked screws (d)
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mobilization. Complete weight-bearing was proscribed for
1 month, subsequently progressive load was allowed with
crutches, except for the patients treated with bone cement,
who had a proscription for 20 days because of the better
mechanical stability given by cement [1]. Active and pas-
sive knee mobilization was allowed immediately on the
first postoperative day.
The functional and radiological outcomes are described
in Table 2.
Before the first surgery, the KSS scores were excellent
in 91.7 % and good in 8.3 %. After the first surgery
(curettage plus osteosynthesis), the KSS scores were
excellent in 66.7 % and good in 33.3 %. After the curet-
tage, filling, and preventive osteosynthesis, the average
ROM of the knee was 130.0 ± 9.8 with a percent of
flexion than contralateral knee of 93.4 ± 6.6. After
hardware removal, an improvement was observed in the
KSS (excellent in 91.7 %, good in 8.3 % of patients), in the
average ROM of the knee (137.0 ± 4.5) and in the per-
cent of flexion compared with contralateral knee (98.1 ±
3.3). Therefore, we observed a functional improvement
after hardware removal although current literature fails to
offer systematic guidelines and doesn’t support the routine
removal of implants [8, 9].
No postoperative fractures in any patients were observed,
either after the first surgery or after hardware removal.
No pain or limping was reported, except in the early
postoperative time, usually solved with drugs (NSAIDs,
paracetamol and codeine based drugs). In two cases
patients had pain due to hardware that was solved after
hardware removal. One case of cutaneous superficial
infection was successfully solved with antibiotic therapy.
No cases of cutaneous necrosis, delayed wound healing,
deep venous thrombosis, infections or recurrence were
observed.
Discussion
Nowadays, in primary and secondary malignant bone
tumors, hemiarthroplasty, arthroplasty and allograft-pros-
thesis-composite (APC), or curettage (associated with local
adjuvants) followed by fixation with plate or intramedul-
lary nail, represent the recommended techniques in most
cases as they provide good mechanical stability, restore
early limb function, and improve quality of life [10–13].
In benign and tumor-like lesions, isolated curettage has
been curative in 95 % of cases; the recurrence rate is









Type of lesion Treatment
1 18 M Pain 7 9 3.5 9 3.5 Low-grade
chondrosarcoma
Curettage, local adjuvant, filling with cement,
osteosynthesis with LCP plate 4.5
2 25 M Pain 10 9 4 9 3.5 Chondroma Curettage, local adjuvant, filling with allograft,
osteosynthesis with LISS plate
3 28 F Pain 9 9 3.5 9 2.5 Giant cell tumor Curettage, local adjuvant, filling with cement,
osteosynthesis with LISS plate
4 45 F Pain 8 9 3 9 3 Bone cyst Curettage,filling with bone graft, osteosynthesis
with LISS plate
5 44 F Pain 8 9 3 9 2.5 Chondroma Curettage, local adjuvant, filling allograft,
osteosynthesis with LCP plate 4.5
6 33 F Pain 12 9 3 9 3 Chondromixoid
fibroma
Curettage, local adjuvant, filling with allograft,
osteosynthesis with LCP plate 4.5
7 29 F Pain 10 9 3.5 9 3 Chondroma Curettage, local adjuvant, filling with allograft,
osteosynthesis with LISS plate
8 31 M Pain 11 9 4 9 3.5 Giant cell tumor Curettage, local adjuvant, filling with cement,
osteosynthesis with LISS plate
9 47 F Pain limping 8 9 3 9 3.5 Low-grade
chondrosarcoma
Curettage, local adjuvant, filling with cement,
osteosynthesis with LISS plate
10 27 M Pain limping 8 9 3.5 9 4 Chondroma Curettage, local adjuvant, filling with allograft,
osteosynthesis with LISS plate
11 17 F Pain limping 7 9 3 9 3 Fibrous dysplasia Curettage, filling with allograft, osteosynthesis
with LCP plate 3.5
12 35 F Pain 8 9 2.5 9 3 Fibrous dysplasia Curettage, filling with bone graft, osteosynthesis
with LCP plate 3.5
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variable and depends on histotype of the lesion [14–16]. In
order to reduce the risk of postoperative fracture favoring
the process of bone consolidation [17], curettage has often
been followed by filling with autologous bone grafts,
allografts, polymethylmethacrylate (PMMA) or bone sub-
stitutes, to provide pain relief and early recovery, and to
preserve structural integrity of the bone and adjacent joint
[14, 18–24]. Nevertheless, some authors have reported that
Fig. 2 A low-grade
chondrosarcoma of the distal
femur (a), treated with curettage
and filling with fibular allograft
(b), and preventive
osteosynthesis (c)

















1 None Normal 140 100 Excellent Excellent 140 100 Excellent
2 None Normal 140 100 Excellent Excellent 140 100 Excellent
3 None Normal 140 100 Excellent Excellent 140 100 Excellent
4 None Normal 120 92 Excellent Excellent 130 93 Excellent
5 Hardware pain Normal 115 82 Good Good 130 93 Excellent
6 None Normal 120 86 Excellent Good 135 Excellent
7 None Normal 125 89 Excellent Excellent 140 100 Excellent




Normal 130 93 Excellent Good 140 100 Good
10 None Normal 140 100 Excellent Excellent 140 100 Excellent
11 None Normal 140 100 Excellent Excellent 140 100 Excellent
12 None Normal 130 93 Excellent Excellent 140 100 Excellent
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in some lesions (especially those in areas of load) this
approach is not sufficient, since it may not assure
mechanical stability of the system, with consequent risk of
postoperative fracture [25]. Moreover, it has been reported
that most benign bone defects will consolidate without the
need for these bone substitutes [17, 22, 24].
Adequate exposure and accurate curettage are essential
to maximize local control, regardless of whether adjuvants
are used or not [15, 16]. The bone window must be large to
allow an adequate curettage, especially in malignant
lesions (to reduce the risk of recurrence). Therefore, this
procedure often weakens the bone, with an increase of the
torsional forces at the level of the bone window, making
necessary the fixation with a plate.
There are few data in the literature that state the precise
dimensions of the lesion that requires preventive
osteosynthesis. Hirn et al. [17] showed a strong correlation
between risk of postoperative fracture and both size and
volume of the cyst. The average size of the cysts that
fractured postoperatively was 108 cm3, and 58 cm3 for the
cysts that did not fracture (p = 0.003). The risk of fracture
was 5 % in patients with cysts less than 60 cm3, and 17 %
for those with cysts larger than 60 cm3 (p = 0.01). The risk
was 3 % when the maximum diameter of the cyst was
B5 cm, but 15 % when the diameter was [5 cm
(p = 0.02). Kundu et al. [26] also showed a correlation
between risk of postoperative fracture and size, volume,
and localization of the cyst. The risk of fracture was lower
in long bones and pelvic bones with cysts less than 70 cm3,
as compared to those with cysts larger than 70 cm3. They
found that average size of the cysts that fractured in long
bones was 126.52 cm3, and 49.352 cm3 for the cysts that
did not fracture. The average size of the cysts that fractured
in long bones of the lower limb was 142.11 cm3, and
53.094 cm3 for the cysts that did not fracture. There was no
correlation between the risk of postoperative fracture and
size/volume of the cyst in short bones.
Others authors concluded that in selected cases pre-
ventive osteosynthesis associated with filling with cement
or bone grafts is recommended to reduce the risk of post-
operative complications and provide early recovery of
mobility [27].
In this case series, filling with bone graft (2 cases) or
allograft (6 cases) or acrylic cement (4 cases) was always
associated with preventive osteosynthesis of the lesion to
increase the mechanical support of the final system.
PMMA is recommended by many authors [1, 4, 18] in
aggressive benign lesions and low-grade malignant lesions.
PMMA provides immediate stability and is always avail-
able in great quantity for large tumor cavities. Additionally,
its exothermic reaction kills tumor cells, therefore
decreasing the risk of recurrence. Allograft and bone sub-
stitutes are not generally indicated in small lesions [17].
The first limitation of this study was that the series was
very small (only 12 patients), and the tumor histotypes
different. Although these 12 patients represent a hetero-
geneous group of diagnoses (that would need different
treatment options), we selected only lesions that needed a
more aggressive approach due to the high risk of postop-
erative fractures: fibrous dysplasia with a very large lesion,
giant cell tumor, chondrosarcoma grade I. Finally, the few
cases of this series and the lack of a control group do not
allow sufficient statistical power to support these conclu-
sions: a larger and multicenter study should be considered
in the future.
In conclusion, preventive osteosynthesis associated with
curettage in benign and low-grade malignant primitive
bone tumors of the distal femur in adult patients reduces
the risk of postoperative fracture, and is associated with a
good clinical and functional outcome. Preventive
osteosynthesis could be indicated for very large lesions
([5 cm, [60 cm3) with residual large bone windows,
lesions of the distal femur and loading zones, in obese
patients and patients with high functional requests, when
local adjuvants are used.
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